Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
University of California, Los Angeles · Heidelberg University · +3 more institutions
Abstract
A recent joint meeting was held on January 30, 2014, with the US Food and Drug Administration (FDA), National Cancer Institute (NCI), clinical scientists, imaging experts, pharmaceutical and biotech companies, clinical trials cooperative groups, and patient advocate groups to discuss imaging endpoints for clinical trials in glioblastoma. This workshop developed a set of priorities and action items including the creation of a standardized MRI protocol for multicenter studies. The current document outlines consensus recommendations for a standardized Brain Tumor Imaging Protocol (BTIP), along with the scientific and practical justifications for these recommendations, resulting from a series of discussions…
Citation impact
- FWCI
- 20.27
- Percentile
- 100%
- References
- 65
Authors
28- BMBenjamin M. EllingsonCorresponding
University of California, Los Angeles, Heidelberg University, University Hospital Heidelberg, Center for Neuro-Oncology, Neurological Surgery
- MBMartin Bendszus
University of California, Los Angeles, Heidelberg University, University Hospital Heidelberg, Center for Neuro-Oncology, Neurological Surgery
- JLJerrold L. Boxerman
University of California, Los Angeles, Heidelberg University, University Hospital Heidelberg, Center for Neuro-Oncology, Neurological Surgery
- DPDaniel P. Barboriak
University of California, Los Angeles, Heidelberg University, University Hospital Heidelberg, Center for Neuro-Oncology, Neurological Surgery
- BJBradley J. Erickson
University of California, Los Angeles, Heidelberg University, University Hospital Heidelberg, Center for Neuro-Oncology, Neurological Surgery
Topics & keywords
- Medicine
- Clinical trial
- Protocol (science)
- Medical physics
- Neuroimaging
- Food and drug administration
- Magnetic resonance imaging
- Brain tumor